Clinical Trial

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Study acronym: SYMPHONY-HF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 4, 2023 (before its estimated June 21, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-22.
Trial Details
NCT Number NCT05919342
Lead Sponsor NHS Greater Glasgow and Clyde
Collaborators: University of Glasgow, National Heart Centre Singapore, Karolinska University Hospital, Uppsala University, Montreal Heart Institute, Rigshospitalet, Denmark, University of British Columbia, The Cleveland Clinic, Université de Montréal, AstraZeneca, Roche Pharma AG, Us2.ai
Conditions Heart Failure, Cardiovascular Diseases
Enrollment 3,904 participants
Start Date 2022-12-22
Primary Completion 2024-06-21 (estimated)
Study Completion 2032-12-21 (estimated)
Updated on ClinicalTrials.gov 2023-08-04